The Global Burden of premature cardiovascular disease, 1990-2019.

Epidemiology Global disease burden Premature cardiovascular mortality

Journal

International journal of cardiology. Cardiovascular risk and prevention
ISSN: 2772-4875
Titre abrégé: Int J Cardiol Cardiovasc Risk Prev
Pays: Netherlands
ID NLM: 9918282077306676

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 02 06 2023
revised: 25 08 2023
accepted: 07 09 2023
medline: 25 10 2023
pubmed: 25 10 2023
entrez: 25 10 2023
Statut: epublish

Résumé

Premature cardiovascular disease (pCVD) definition varies in literature, with age cut-offs ranging from 50-65 years. While there is some literature available on pCVD in North America, comprehensive data on its global burden is still lacking which hinders the development of efficient strategies for early detection and prevention. In this study we aimed to investigate the global trends in pCVD related morbidity and mortality from 1990 to 2019. The 1990-2019 Global Burden of Disease (GBD) database was utilized to examine global trends in cardiovascular disease-related total mortality, mortality rates, and Disability-Adjusted Life Years (DALYs) within individuals aged 15-49 years. The findings were further analyzed based on factors such as age, sex, and Socio-Demographic Index (SDI). From 1990 to 2019, the number of global annual pCVD deaths increased by 25%, from 992,067 (95% UI 1,042,261 - 946,383) to 1,241,484 (95% UI 1,339,193 -1,146,252). The rate of associated mortality decreased by 13%. Metabolic conditions were the most significant risk factors for pCVD mortality. Ischemic heart disease and stroke are the leading causes of death across all age groups. pCVD mortality presented progressive widening between high and low SDI regions. Additionally, sex-specific disparities in CVD mortality were significantly greater in the premature age group as compared to all-age groups. pCVD is an increasingly significant global cause of morbidity and mortality that disproportionately affects males and individuals living in less privileged regions. Furthermore, ischemic heart disease and stroke were identified as the main drivers of pCVD global burden.

Identifiants

pubmed: 37876911
doi: 10.1016/j.ijcrp.2023.200212
pii: S2772-4875(23)00045-4
pmc: PMC10590819
doi:

Types de publication

Journal Article

Langues

eng

Pagination

200212

Informations de copyright

© 2023 Published by Elsevier B.V.

Déclaration de conflit d'intérêts

None.

Références

Can J Cardiol. 2020 Sep;36(9):1352-1361
pubmed: 32622878
Can J Neurol Sci. 2021 Sep;48(5):685-689
pubmed: 33213535
Nat Rev Cardiol. 2018 Feb;15(2):106-119
pubmed: 28933782
Heart Views. 2011 Jul;12(3):121-7
pubmed: 22567201
World J Emerg Med. 2011;2(1):18-23
pubmed: 25214977
Circulation. 2015 Sep 15;132(11):997-1002
pubmed: 26302759
BMC Cardiovasc Disord. 2020 Apr 25;20(1):201
pubmed: 32334525
Expert Rev Cardiovasc Ther. 2006 May;4(3):345-51
pubmed: 16716095
BMJ Open. 2014 Dec 30;4(12):e005663
pubmed: 25550291
J Addict. 2018 Oct 24;2018:8081670
pubmed: 30473903
MMWR Morb Mortal Wkly Rep. 2016 Jan 08;64(52):1393-7
pubmed: 26741238
Dialogues Clin Neurosci. 2007;9(1):71-83
pubmed: 17506227
J Am Coll Cardiol. 2016 Apr 5;67(13):1516-1518
pubmed: 27150681
Obes Rev. 2016 Feb;17(2):95-107
pubmed: 26696565
J Am Coll Cardiol. 2018 Sep 18;72(12):1397-1416
pubmed: 30213333
J Am Heart Assoc. 2019 Jul 16;8(14):e012178
pubmed: 31280642
Sci Rep. 2022 Feb 2;12(1):1810
pubmed: 35110692
Ann Thorac Surg. 2021 Apr;111(4):1394-1400
pubmed: 32771467
Rev Clin Esp (Barc). 2022 Jun-Jul;222(6):348-353
pubmed: 34154974
J Gen Intern Med. 2021 Apr;36(4):1144-1146
pubmed: 32193815
Nutrients. 2020 Sep 25;12(10):
pubmed: 32992705
Heart. 2016 Dec 15;102(24):1945-1952
pubmed: 27550425
Int J Epidemiol. 2019 Dec 1;48(6):1815-1823
pubmed: 31378814
Circ Res. 2017 Jan 20;120(2):366-380
pubmed: 28104770
Ann Epidemiol. 2018 Oct;28(10):686-690.e2
pubmed: 30087013
Eur J Prev Cardiol. 2019 Jul;26(10):1096-1103
pubmed: 30691303
Lancet. 2019 Aug 24;394(10199):652-662
pubmed: 31327566
Int J Mol Sci. 2018 Nov 01;19(11):
pubmed: 30388787
BMJ Glob Health. 2017 Mar 27;2(2):e000298
pubmed: 28589033
Cardiol Res Pract. 2012;2012:658526
pubmed: 22111029
Int J Cardiol. 2018 Oct 15;269:7-12
pubmed: 30005835
Lancet Healthy Longev. 2022 Nov;3(11):e754-e776
pubmed: 36273485
Surgery. 2021 Jul;170(1):13-17
pubmed: 33714616
J Clin Hypertens (Greenwich). 2015 Sep;17(9):657-62
pubmed: 26346989
J Am Coll Cardiol. 2021 Feb 23;77(7):1021-1023
pubmed: 33602460
J Immigr Minor Health. 2013 Oct;15(5):858-65
pubmed: 22915055
J Clin Med. 2021 Feb 05;10(4):
pubmed: 33562759
Nat Rev Cardiol. 2013 May;10(5):284-92
pubmed: 23546444
Circulation. 2021 Apr 13;143(15):1468-1480
pubmed: 33813836
Circulation. 2021 Oct 19;144(16):1272-1279
pubmed: 34662161
Pediatr Clin North Am. 2022 Dec;69(6):1165-1180
pubmed: 36880928
BMJ Open. 2022 Sep 8;12(9):e061350
pubmed: 36691204
J Transl Med. 2022 Aug 2;20(1):344
pubmed: 35918724
BMC Health Serv Res. 2023 Mar 7;23(1):222
pubmed: 36882833
Medicine (Baltimore). 2018 Aug;97(31):e11744
pubmed: 30075591
Circulation. 2019 Feb 19;139(8):1025-1035
pubmed: 30779652
Expert Rev Pharmacoecon Outcomes Res. 2021 Aug;21(4):559-570
pubmed: 33565901
Am J Cardiol. 2019 Jul 1;124(1):1-7
pubmed: 31029413
Adv Nutr. 2016 Nov 15;7(6):1052-1065
pubmed: 28140323
J Am Heart Assoc. 2022 Oct 4;11(19):e026497
pubmed: 36172970
Circ Cardiovasc Qual Outcomes. 2018 Feb;11(2):e004437
pubmed: 29449443
BMC Public Health. 2017 Aug 29;17(1):683
pubmed: 28851330
Glob Heart. 2018 Dec;13(4):293-303
pubmed: 30245177
Stroke. 2018 Apr;49(4):e157-e159
pubmed: 29581347
NCHS Data Brief. 2017 Oct;(288):1-8
pubmed: 29155689
J Am Coll Cardiol. 2022 Dec 20;80(25):2361-2371
pubmed: 36368511
Lancet. 2020 Oct 17;396(10258):1204-1222
pubmed: 33069326
J Am Coll Cardiol. 2020 Dec 22;76(25):2982-3021
pubmed: 33309175
BMC Neurol. 2022 Sep 6;22(1):335
pubmed: 36068544

Auteurs

Hossam Lababidi (H)

Faculty of Medicine, American University of Beirut, Beirut, Lebanon.

Pedro Rvo Salerno (PR)

Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.

Sojin Youn Wass (SY)

Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.

Neda Shafiabadi Hasani (N)

Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.

Brendan Bourges-Sevenier (B)

Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.

Sadeer Al-Kindi (S)

Division of Cardiovascular Prevention and Wellness, DeBakey Heart and Vascular Center, Houston Methodist, Houston, TX, USA.

Classifications MeSH